Cargando…

Malignant Hidradenocarcinoma of the Axilla

Malignant hidradenocarcinoma is a very rare and highly aggressive primary skin neoplasm that arises in the eccrine sweat glands. Diagnosis is typically made with histopathological evaluation after excisional biopsy. Reports of this tumor are scarce in the literature, thus making its characterization...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Evan P, Keyes, Jonathan, Zayat, Vania, Caudill, Jeremy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096074/
https://www.ncbi.nlm.nih.gov/pubmed/32226692
http://dx.doi.org/10.7759/cureus.7091
_version_ 1783510746515111936
author Johnson, Evan P
Keyes, Jonathan
Zayat, Vania
Caudill, Jeremy
author_facet Johnson, Evan P
Keyes, Jonathan
Zayat, Vania
Caudill, Jeremy
author_sort Johnson, Evan P
collection PubMed
description Malignant hidradenocarcinoma is a very rare and highly aggressive primary skin neoplasm that arises in the eccrine sweat glands. Diagnosis is typically made with histopathological evaluation after excisional biopsy. Reports of this tumor are scarce in the literature, thus making its characterization and management particularly challenging. A 71-year-old male presented in the clinic with swelling of the left lateral axilla on routine dermatological examination. Clinically, the lesion was suspected to be a capillary hemangioma. Upon surgical excision, the specimen was diagnosed as malignant hidradenocarcinoma based on histological characterization with immunohistochemical staining. Subsequent wide excision with sentinel lymph node biopsy was performed, which came back negative for residual tumor and metastasis. Due to the low incidence of this cancer and the markedly poor prognosis, accurate diagnosis of these tumors is highly important. Wide excisional biopsy and sentinel lymph node biopsy appear to be the most common initial treatment plans based on the available literature. With high rates of recurrence and metastasis, there remains the need to characterize effective adjuvant therapy for the post-operative management of hidradenocarcinoma.
format Online
Article
Text
id pubmed-7096074
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-70960742020-03-28 Malignant Hidradenocarcinoma of the Axilla Johnson, Evan P Keyes, Jonathan Zayat, Vania Caudill, Jeremy Cureus Pathology Malignant hidradenocarcinoma is a very rare and highly aggressive primary skin neoplasm that arises in the eccrine sweat glands. Diagnosis is typically made with histopathological evaluation after excisional biopsy. Reports of this tumor are scarce in the literature, thus making its characterization and management particularly challenging. A 71-year-old male presented in the clinic with swelling of the left lateral axilla on routine dermatological examination. Clinically, the lesion was suspected to be a capillary hemangioma. Upon surgical excision, the specimen was diagnosed as malignant hidradenocarcinoma based on histological characterization with immunohistochemical staining. Subsequent wide excision with sentinel lymph node biopsy was performed, which came back negative for residual tumor and metastasis. Due to the low incidence of this cancer and the markedly poor prognosis, accurate diagnosis of these tumors is highly important. Wide excisional biopsy and sentinel lymph node biopsy appear to be the most common initial treatment plans based on the available literature. With high rates of recurrence and metastasis, there remains the need to characterize effective adjuvant therapy for the post-operative management of hidradenocarcinoma. Cureus 2020-02-24 /pmc/articles/PMC7096074/ /pubmed/32226692 http://dx.doi.org/10.7759/cureus.7091 Text en Copyright © 2020, Johnson et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Pathology
Johnson, Evan P
Keyes, Jonathan
Zayat, Vania
Caudill, Jeremy
Malignant Hidradenocarcinoma of the Axilla
title Malignant Hidradenocarcinoma of the Axilla
title_full Malignant Hidradenocarcinoma of the Axilla
title_fullStr Malignant Hidradenocarcinoma of the Axilla
title_full_unstemmed Malignant Hidradenocarcinoma of the Axilla
title_short Malignant Hidradenocarcinoma of the Axilla
title_sort malignant hidradenocarcinoma of the axilla
topic Pathology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096074/
https://www.ncbi.nlm.nih.gov/pubmed/32226692
http://dx.doi.org/10.7759/cureus.7091
work_keys_str_mv AT johnsonevanp malignanthidradenocarcinomaoftheaxilla
AT keyesjonathan malignanthidradenocarcinomaoftheaxilla
AT zayatvania malignanthidradenocarcinomaoftheaxilla
AT caudilljeremy malignanthidradenocarcinomaoftheaxilla